Biotinylated Human CCR8 Protein, His,Flag Tag&Avitag™ (Detergent)

ユーザーレビュー
製品番号/仕様
価格
数量
CC8-H82D3-20ug
$1240.00
CC8-H82D3-100ug
$3400.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    CC chemokine receptor 8, CDw198, ChemR1, CKRL1, CKR-L1, CKRL1, CY6, GPRCL1, GPRCY6, GPR-CY6, TER-1

  • Source

    Detergent Biotinylated Human CCR8 Protein, His,Flag Tag&Avitag (CC8-H82D3) is expressed from human 293 cells (HEK293). It is a membrane protein, contains complete wild type 7-transmembrane domains (TMD) and extracellular domain (ECD).

  • Molecular Characterization

    This protein carries a polyhistidine tag at the C-terminus and a Flag tag at the C-terminus followed by an Avi tag (Avitag™). The protein has a calculated MW of 60.5 kDa.

    *The detergent Buffer B (Cat. No. LG-13) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of detergent.
    Detergent buffer is INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove detergent.
    Detergent buffer is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, Buffer B, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Bioactivity-ELISA

     CCR8 ELISA

    Immobilized Biotinylated Human CCR8 Protein, His,Flag Tag&Avitag (Cat. No. CC8-H82D3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-CCR8 Antibody, Human IgG1 with a linear range of 0.2-31 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     CCR8 SPR

    Anti-CCR8 Antibody, Human IgG1 captured on Protein A Chip can bind Biotinylated Human CCR8 Protein, His,Flag Tag&Avitag (Cat. No. CC8-H82D3) with an affinity constant of 115 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol
  •  CCR8 SPR

    Monoclonal Anti-CCR8 Antibody, Human IgG1 captured on Protein A Chip can bind Biotinylated Human CCR8 Protein, His,Flag Tag&Avitag (Cat. No. CC8-H82D3) with an affinity constant of 97.6 nM as determined in a SPR assay (in presence of LG-13) (Biacore 8K) (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

A chemokine receptor predominantly marking tumor-infiltrating regulatory T cells (Tregs) rather than peripheral Tregs. Targeting CCR8 enables selective depletion of immunosuppressive cells within the tumor microenvironment, thereby reinvigorating anti-tumor immunity without triggering systemic autoimmunity.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    C-C chemokine receptor type 8

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    20 詳細

  • 最新の開発ステージ:

    Phase 3 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8